STAT

APRIL 10, 2024

stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country. The number of ongoing and active drug shortages in the U.S. The reasons are varied, although many remain a mystery.

Chemotherapy 142

Chemotherapy Immunization 142

STAT

APRIL 11, 2024

stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country, STAT tells us. Unresolved The number of ongoing and active drug shortages in the U.S.

Chemotherapy 111

Chemotherapy Immunization 111

pharmaphorum

SEPTEMBER 13, 2022

While they may not have known it at the time, through their work Ehrlich and Metschnikow formed the cornerstone of modern immunology, including chemoreceptor and chemotherapy concepts that revolutionised blood cancer treatment over the following century. 1942 – Chemotherapy moves from trenches to treatment .

Chemotherapy 98

Chemotherapy Immunization FDA Documentation 98

pharmaphorum

JUNE 8, 2021

Chemotherapy still accounted for 72.6% Chemotherapy still plays a significant role in oncology treatment, accounting for 72.6% While all of the top ten best-selling oncology drugs in the US in 2019 were innovative therapies, four out of the top ten best-selling oncology drugs in China were for conventional chemotherapy. “In

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

European Pharmaceutical Review

DECEMBER 12, 2023

IPH5201 is being investigated in a Phase II trial, MATISSE, in combination with durvalumab (anti-PD-L1) and chemotherapy, in patients with resectable early-stage NSCLC. Innate Pharma also developing IPH5201 in collaboration with AstraZeneca. He is a member of the company’s Executive Board.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

Pharmaceutical Technology

FEBRUARY 13, 2023

The first concept for a PROTAC was published in 2001, and recently these protein degraders have gained rapid momentum as a promising novel modality. Faslodex will be administered in the control arm of the Phase III study, allowing for direct comparison between the two ER degraders.

Chemotherapy 59

Chemotherapy Compounding Dosage Immunization 59

The Checkup by Singlecare

AUGUST 8, 2024

Drug shortages in the United States are extremely common, with the number of ongoing and active shortages at their highest since the American Society of Health-System Pharmacists (ASHP) began tracking in 2001. Many factors cause medication shortages. According to the FDA, manufacturing issues are the main reason for drug shortages.

Compounding 52

Compounding FDA Compounding Pharmacies Community Pharmacies 52